Study of Mycobacterial Infections

计划入组 1,000 人 · 首次发布于 2001 年 6 月 29 日

Study of Nontuberculous Mycobacterial Lung Disease

计划入组 300 人 · 首次发布于 2009 年 9 月 2 日

Treatment Outcomes in Patient With Nontuberculous Mycobacterial Disease

计划入组 150 人 · 首次发布于 2012 年 9 月 7 日

Mycobacterial tolerance inhibitors (tuberculosis)

Undisclosed program (mycobacterial infection)

non-tuberculosis mycobacterial diseases/ tuberculosis therapy

Suzanne Morin

United States

SORIN CRM SAS

France

Mitsui Norin Co., Ltd.

Japan

AI-Designed 'WRAP' Proteins Solve Decades-Old Membrane Protein Solubility Problem, Opening Door to Syphilis Vaccine

Omadacycline Shows Promise in Phase II Trial for Nontuberculous Mycobacterial Pulmonary Disease

Discovery of Arr-X: A Novel, Highly Efficient Rifamycin-Inactivating Enzyme Family Reveals New Antibiotic Resistance Mechanisms Across Mycobacteria